Clinical Trials Logo

Clinical Trial Summary

This Phase II study is to determine the efficacy and safety of MR-Linac Guided Radiotherapy in patients with inoperable mediastinal tumors.


Clinical Trial Description

This Phase II study is to determine the efficacy and safety of MR-Linac Guided Radiotherapy in patients with inoperable mediastinal tumors. Patients will receive radiotherapy on the MR-Linac treatment machine. The primary end point is 2-year local-recurrence free survival. The secondary end points are objective response rate, 2-y PFS, 2-y OS, safety of treatment, dose coverage of targets and dose to normal organs. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05163509
Study type Interventional
Source Sun Yat-sen University
Contact Daquan Wang, M.D
Phone +86-020-87343031
Email wangdq@sysucc.org.cn
Status Recruiting
Phase Phase 2
Start date October 1, 2021
Completion date October 1, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT03613272 - The Curative Effect of Extended Thymectomy Performed Through Subxiphoid-right VATS Approach With Elevation of Sternum N/A
Completed NCT03439696 - Needlescopic-assisted Uniportal vs Uniportal VATS N/A
Active, not recruiting NCT05682742 - Clinical Investigation of the da Vinci Surgical System N/A
Not yet recruiting NCT03214341 - Assessment of Mediastinal Masses With Diffusion Weighted MR Imaging N/A
Active, not recruiting NCT05267496 - Oscillating Positive Expiratory Pressure Therapy for Patients With Thoracic Neoplasms Undergoing Chest Surgery N/A
Completed NCT03537430 - Totally no Tube (TNT) Uniportal Video-assisted Thoracoscopic Surgery (VATS) VS Traditional Uniportal VATS for Mediastinal Tumor N/A